Pre-cleared analytical batches verified via 400MHz 1H-NMR, LC-MS, and reverse-phase UHPLC. Shipped in pharmaceutical cold-chain packaging designed for Indian ambient temperatures.
High-purity influenza hemagglutinin fragment utilized extensively by immunology research labs and diagnostic assay developers across India.
Potent oligopeptide Angiotensin IV analog with validated blood-brain barrier permeability markers, supplied to neurological institutes in India.
Pure crystalline GHK copper peptide raw powder and sterile lyophilized vials optimized for dermatological and anti-fibrotic regenerative trials in India.
Research-grade RFamide neuropeptide synthesized for neuro-endocrinology receptor binding analysis at leading academic and clinical CROs across India.
India's biopharmaceutical infrastructure is undergoing a massive evolutionary leap. From being recognized historically as the "pharmacy of the world" for small-molecule generics, India is now a premier international cluster for preclinical drug discovery, targeted receptor research, and high-tier Contract Research Organizations (CROs).
India faces substantial chronic illness burdens associated with oncological muscle wasting (cachexia), sarcopenia in aging demographics, and hypogonadism. Research universities in New Delhi, Bengaluru, and Pune are actively testing selective androgen receptor ligands to circumvent steroid-induced hepatotoxicity while stimulating anabolism.
Genome Valley in Hyderabad and Electronic City in Bengaluru host dozens of global contract analytical testing hubs. Indian CROs require steady, kilogram-scale imports of reference SARMs (such as Enobosarm, RAD-140, LGD-4033, and MK-677) with absolute isomeric validation to support multinational screening trials.
Indian procurement teams consistently flag two critical failure points when sourcing raw APIs: under-dosed materials broker-swapped through secondary trading houses, and shipment degradation due to high humidity and temperature extremes during customs quarantine at inland container depots.
Bridging synthetic organic chemistry with digitalized manufacturing excellence. How automated continuous-flow reactors and advanced chiral purification ensure our active compounds meet the rigorous specifications demanded by Indian scientists.
Selective Androgen Receptor Modulators hinge on extraordinary stereospecificity. The biological efficacy of an arylpropionamide or pyrrolidinyl core is determined by enantiomeric pure conformation. Traditional batch crystallization frequently results in residual (R)-enantiomers that exhibit poor receptor binding or off-target antagonist activity.
Our Factory 4.0 facility utilizes automated continuous-flow microreactors coupled with simulated moving bed (SMB) chiral chromatography. This approach guarantees an enantiomeric excess (%ee) surpassing 99.8%, effectively eliminating spurious stereoisomers before the intermediate crystallization phase.
Looking toward the technological horizon, our R&D pipeline is pioneering Peptide-SARM Molecular Hybrids (PSMH). By covalently linking anabolic ligand backbones to signaling peptide sequences via acid-labile hydrazone linkers, we supply Indian biomedical laboratories with novel tools targeting site-specific tissue repair without systemic hormonal perturbation.
All analytical release data are structured to seamlessly cross-reference with standard entry audits required by Indian drug testing bodies.
| Analytical Parameter | Common Market Trader Grade | Our Factory 4.0 Standard for India | Testing Methodology | Compliance Status |
|---|---|---|---|---|
| Chemical Purity (Assay) | 95.0% – 97.5% (Variable) | ≥ 99.0% – 99.8% | Reverse-Phase UHPLC (Area %) | ✓ Audit Certified |
| Stereochemical Purity (%ee) | < 95% (Unchecked Chiral Centers) | > 99.5% Enantiomeric Excess | Chiral Column HPLC / Polarimetry | ✓ Zero Racemization |
| Residual Organic Solvents | Exceeds ICH limits (DCM/Ether trace) | Below Detection Limits (ICH Q3C) | Headspace Gas Chromatography (GC-MS) | ✓ Fully Compliant |
| Heavy Metals (Pb, As, Cd, Hg) | Often untested / >20 ppm | ≤ 5 ppm Combined | ICP-MS Inductively Coupled Plasma | ✓ Heavy Metal Free |
| Bacterial Endotoxins | Not specified | < 0.05 EU/mg for Vials | Kinetic Turbidimetric LAL Assay | ✓ Sterile Lab Ready |
Why procurement teams from Mumbai, Hyderabad, and Bengaluru bypass local tier-3 distributors and partner directly with our Hebei synthesis facility.
Unlike secondary formulators that depend on third-party raw chemicals, our integrated production base controls the synthesis of basic building blocks: 2-hydroxy-2-methylpropanoic acid derivatives, specialized fluorinated benzenes, and chiral epoxides. This insulates Indian enterprise partners from global supply shocks.
Whether an academic laboratory at the Indian Institute of Science (IISc) requires 10 grams of reference-grade standard for bio-receptor binding, or a commercial formulation plant in Gujarat needs 50 kilograms of bulk raw powder, our production reactor capacities scale seamlessly without recalculating synthetic routes or yield decay.
By executing direct factory-to-importer supply contracts, Indian laboratories circumvent intermediary markups imposed by trading syndicates in Dubai or Singapore. Savings of up to 45% are returned directly to your R&D budget while unlocking direct communication with bench-level process chemists.
Mastering the complexities of cross-border biochemical freight. How we protect every shipment bound for Air Cargo Complexes in Mumbai (BOM), Delhi (DEL), Hyderabad (HYD), and Bengaluru (BLR).
Misclassification is the number one cause of cargo detention at Indian customs. Our dedicated export documentation specialists prepare standardized, pre-vetted export declarations aligned with the Indian ICEGATE EDI portal:
India’s tropical climate presents harsh environmental hurdles: ambient summer temperatures exceeding 42°C and monsoon relative humidities above 85% can rapidly hydrolyze sensitive peptide bonds and degrade dry powder stability.
Explore our high-demand compounds engineered for analytical accuracy, metabolic discovery, and cellular regeneration studies across the Indian biotechnology market.
191-amino-acid recombinant somatropin sequence with high biological potency, verified via size-exclusion chromatography (SEC-HPLC).
Synthetic decapeptide GnRH agonist engineered for oncology and reproductive hormone pathway exploration across clinical testing centers.
High-affinity LH-RH decapeptide synthesized for veterinary research, endocrine assay calibration, and receptor-binding research in India.
Stabilized lipolytic C-terminal somatotropin fragment (Tyr-hGH 177-191) supplied in wholesale quantities to Indian biomedical research institutes.
Ultra-pure oxidized Nicotinamide Adenine Dinucleotide (NAD+) crystalline raw powder for mitochondrial metabolism and longevity research.
Tripeptide C-terminal sequence of alpha-MSH with pronounced anti-inflammatory mechanisms, investigated for IBD and gut barrier integrity models in India.
Cost-optimized, laboratory-certified recombinant human growth hormone reference standard formulated for assay calibration and cell line proliferation.
Synthetic pineal tetrapeptide (Ala-Glu-Asp-Gly) recognized for telomerase activity modulation and anti-senescence cellular research in India.
Authoritative guidance addressing regulatory classification, analytical validation, and logistical protocols for Indian laboratory directors and corporate procurement officers.
Under the Indian Drugs and Cosmetics Act and subsequent CDSCO directives, Selective Androgen Receptor Modulators are categorized as non-approved active pharmaceutical substances for human consumption. However, legitimate academic institutions, universities, pharmaceutical testing facilities, and CROs can legally import research-grade SARMs and peptides for in vitro evaluation and laboratory testing under the 'Test License' or Research NOC protocols using appropriate HS classification codes.
Every single batch exported to India is accompanied by a dual-verified, traceable Certificate of Analysis (COA). We provide actual high-resolution analytical UHPLC chromatograms (displaying column parameters, flow rate, and peak area integration ≥99%), Mass Spectrometry (LC-MS / Q-TOF) for molecular mass verification, and 1H-NMR spectra confirming absence of residual synthesis reagents or solvent degradation.
We deploy validated climate-resilient packaging configurations. Peptides and heat-sensitive APIs are lyophilized into high-density crystal matrices with moisture levels below 0.5%, packed in nitrogen-purged borosilicate vials, placed inside insulated VIP shippers with phase-change cold packs, and routed via dedicated express air connections to minimize transit exposure times at Indian customs clearance points.
Yes. Our Factory 4.0 infrastructure specializes in custom contract synthesis (mg scale to multi-kilogram production). We offer tailored vial fills (e.g., 2mg, 5mg, 10mg, 50mg), vacuum-sealed bulk aluminum containers, custom batch labeling matching client SKU specifications, and third-party laboratory re-test authorization prior to dispatch.
We accommodate standard international commercial payment rails including Telegraphic Transfer (T/T), formal proforma invoices against corporate purchase orders (POs), and documented escrow structures. Our quality assurance team facilitates virtual factory audits, provides facility documentation (ISO9001/GMP conformity certificates), and supplies sample pilot quantities for analytical pre-qualification.
Domestic chemical distributors in India typically source from secondary brokers in Europe, Dubai, or Singapore, adding a 40% to 80% price surcharge alongside unpredictable batch variance. Contracting directly with our synthesis reactors ensures true first-hand primary manufacturer pricing, unadulterated batch identity, and direct access to raw manufacturing chromatograms.
